Pascal Soriot is staying at AstraZeneca after all, confirming upcoming presentation - reports
AstraZeneca has stayed mum for two long days filled with an intense round of rumors and speculation over the future of their CEO, Pascal Soriot. But the latest report out of London is that Soriot has decided to stay with the pharma giant after all, forgoing a reported offer of a $20 million bonus and a chance to reorganize a troubled Teva. And the company, while staying silent on the story, is confirming plans for Soriot to make a key presentation in about two weeks.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.